跳至主要内容
临床试验/NCT04315454
NCT04315454Unknown1 期

The Analgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery

South Egypt Cancer Institute1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
30
试验地点
1
主要终点
morphine consumption

研究概览

简要总结

To study analgesic efficacy &safety of bilateral erector spinae block for upper abdominal cancer surgery as apart of multimodal analgesia.

详细描述

Patients will be randomly assigned using computer generated randomization program (http://www.randomizer.org) into two groups, each group of the them consist of 15 patients:

GROUP (A): {CONTROL GROUP} Patient will receive 20 ml of normal saline into interfascial plane between rhomboidus major &erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side .

Group (B):

Patient will receive 20 mg 0.25% Levobupivacaine bilaterally as above 10 mg each side.

Preoperatively & post-operatively procedures:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient subjected to major upper abdominal cancer surgery.
  • The enrolled age will be from 18-70 years old.
  • ASA: I-III, NYHA: I-III.

排除标准

  • ASA & physical status (NYHA) > III.
  • Pregnant women.
  • Body mass index >40 kg/m
  • Pre-operative opioid consumption.
  • Contraindication or patient's refusal of the procedure.
  • Un co-operative patient.
  • Coagulopathy, skin infection, significant organ dysfunction or drug allergy.

研究组 & 干预措施

Group A

Placebo Comparator

patients will receive 20 ml of normal saline into interfascial plane between rhomboids major &erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side.

干预措施: Levobupivacaine (Drug)

Group B

Experimental

Patients will receive 20 mg 0.25% Levobupivacaine into the interfascial plane between rhomboids major &erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side.

干预措施: Levobupivacaine (Drug)

结局指标

主要结局

morphine consumption

时间窗: 24 hours

Decrease morphine consumption.

次要结局

  • blood gas(24 hours)
  • Hemodynamic(24 hours)
  • VAS score(24 hours)
  • patient satisfaction(24 hours)

研究者

发起方
South Egypt Cancer Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Romany Gamal Rezk Bakeet

anesthesia specialist

South Egypt Cancer Institute

研究点 (1)

Loading locations...

相似试验

Aalgesic Efficacy of Erector -Spinae Technique With... | 临床试验